Clinical trial
Study to Assess the Clinical Validity of Konectom™ in Adults Living With Neuromuscular Disorders
NCT05109637 is registered in ClinicalTrials.gov with Biogen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study to Assess the Clinical Validity of Konectom™ in Adults Living With Neuromuscular Disorders
- Lead sponsor
- Biogen
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 10, 2022
- Completion date
- July 25, 2023
- Enrollment
- 93 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
spinal muscular atrophy